Chronic Thromboembolic Pulmonary Hypertension: An Observational Study
Authors:
- Barbara RuaroBarbara Ruaro
- Paola ConfalonieriPCPaola Confalonieri
- Gaetano CaforioGCGaetano Caforio
- Elisa BaratellaEBElisa Baratella
- Riccardo PozzanRPRiccardo Pozzan
- Stefano TavanoStefano Tavano
- Chiara BozziCBChiara Bozzi
- Selene LerdaSLSelene Lerda
- Pietro GeriPGPietro Geri
- Marco BioloMBMarco Biolo
- Maurizio CortaleMCMaurizio Cortale
- Marco ConfalonieriMarco Confalonieri
Open Access
Abstract
Background and Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) has a high mortality. The treatment of CTEPH could be balloon pulmonary angioplasty (BPA), medical (MT) or pulmonary endarterectomy (PEA). This study aims to assess the clinical characteristics of CTEPH patients, surgically or medically treated, in a pulmonology referral center. Materials and Methods: A total of 124 patients with PH with suspected CTEPH (53 male subjects and 71 female subjects; mean age at diagnosis 67 ± 6) were asked to give informed consent and then were evaluated. The presence of CTEPH was ascertained by medical evaluations, radiology and laboratory tests. Results: After the evaluation of all clinical data, 65 patients met the inclusion criteria for CTEPH and they were therefore enrolled (22 males and 43 females; mean age at diagnosis was 69 ± 8). 26 CTEPH patients were treated with PEA, 32 with MT and 7 with BPA. There was a statistically significant age difference between the PEA and MT groups, at the time of diagnosis, the PEA patients were younger than the MT patients, whereas there was no statistically significant difference in other clinical characteristics (e.g., smoking habit, thrombophilia predisposition), as well as functional and hemodynamic parameters (e.g., 6-min walk test, right heart catheterization). During three years of follow-up, no patients in the PEA groups died; conversely, eleven patients in the MT group died during the same period (p < 0.05). Furthermore, a significant decrease in plasma BNP values and an increase in a meter at the six-minute walk test, 1 and 3 years after surgery, were observed in the PEA group (p < 0.05). Conclusions: This study seems to confirm that pulmonary endarterectomy (PEA) can provide an improvement in functional tests in CTEPH.Keywords
This publication has 73 references indexed in Scilit:
- Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary HypertensionCirculation: Cardiovascular Interventions, 2012
- Diagnosis of chronic thromboembolic pulmonary hypertensionNuclear Medicine Communications, 2012
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Circulation, 2011
- Bosentan for patients with chronic thromboembolic pulmonary hypertensionEuropean Journal of Internal Medicine, 2009
- Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary HypertensionJACC, 2008
- Pulmonary Hypertension and Thyroid DiseaseChest, 2007
- Ventilation-Perfusion Scintigraphy Is More Sensitive than Multidetector CTPA in Detecting Chronic Thromboembolic Pulmonary Disease as a Treatable Cause of Pulmonary HypertensionJournal of Nuclear Medicine, 2007
- Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary EmbolismNew England Journal of Medicine, 2004
- High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertensionThrombosis and Haemostasis, 2003
- Pulmonary thromboendarterectomy – risk factors for early survival and hemodynamic improvementEuropean Journal of Cardio-Thoracic Surgery, 2001